<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02592655</url>
  </required_header>
  <id_info>
    <org_study_id>HCT001</org_study_id>
    <nct_id>NCT02592655</nct_id>
  </id_info>
  <brief_title>A Transparent Elasticized Adhesive Occlusive Compression Bandage for Use as an Arterial Tourniquet</brief_title>
  <official_title>Randomized Sequence, Assessor-Blind, Cross-Over Study of a Windlass Tourniquet, a Pneumatic Tourniquet and an Elastic Adhesive Bandage for Use as a Tourniquet</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Marcus Migura</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mercy Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Migura, Marcus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This cross-over study of twenty five (anticipated) healthy human subjects will utilize two
      active control devices, and two different widths of the investigational device. One active
      control is representative of the usual care tourniquet applied in hospital settings. The
      second active control is a windlass tourniquet representative of the pre-hospital and
      military usual care tourniquet device. Two inch and four inch widths of the investigational
      device will be evaluated. The purpose of this study is to characterize and compare
      investigational and control tourniquet safety and efficacy. All tourniquets will be applied
      to the upper thigh. Efficacy data is provided by the presence or absence of popliteal flow
      when assessed with ultrasound. Mapping of interface pressures between the skin and the
      tourniquet will provide safety data. A minimum washout of five minutes will be allowed
      between tourniquet applications. All interventions will be applied in one visit. No follow up
      visit is anticipated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a small study of 19 participants conducted over only two days. All data for this
      study is collected by the study.

      Tourniquet application:

      All tourniquet applications conducted with the participant seated on the edge of an exam
      table with one leg hanging off the side, and the leg for tourniquet application extended
      outward, with the mid calf resting on a support. This position permits access to the
      popliteal artery for ultrasonography while the investigator has access to apply the
      tourniquet. The lower edge of each tourniquet is aligned just above the middle of the thigh.
      All tourniquets are applied over the pressure mapping sensor. The sensor is slightly thicker
      than denim jeans. Extra care must be taken to ensure that the material of the sensor does not
      interfere with removing the slack from the windlass tourniquets before turning the windlass
      to apply final pressure.

      When a second windlass tourniquet is to be applied it is applied just above or proximal to
      the first windlass tourniquet. The windlass of each tourniquet are located as far from each
      other as possible. Meaning that if the windlass of the first tourniquet is the twelve o'clock
      position then the windlass of the second tourniquet is positioned at the six o'clock
      position. The strap of each tourniquet cannot slip over the windlass of the other. This 6 and
      12 positioning prevents the strap of the second windlass tourniquet from slipping over the
      first as it is tightened.

      When the tape tourniquet is applied, it is elongated, stretched as it is layered over the
      preceding layer with at least one half over lap. The tape tourniquet used in this study is
      similar to, but not the same as the product called manufactured by Entrotech, called &quot;Battle
      Wrap.&quot; Results similar to this study should not be expected with the &quot;Battle Wrap&quot; product.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Radiologist Limb Occlusion Assessment</measure>
    <time_frame>For 1 sustained minute after application of each tourniquet intervention.</time_frame>
    <description>Duplex and color flow ultrasound are used to assess distal blood flow at the popliteal artery for 1 sustained minute following the application of a each tourniquet intervention to the middle upper thigh. If no flow is observed for 1 sustained minute then it is considered successful occlusion. A still image is then saved for later evaluation by the blinded outcome assessor.
The 5 cm tape was discontinued after the 4th participant because the tape was considered to unacceptably narrow after stretching and this was considered a mechanical failure even if occlusion was observed. Therefore the 5 cm tape data was not evaluated by the radiologist.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Investigator Limb Occlusion Assessment</measure>
    <time_frame>For 1 sustained minute after application of each tourniquet intervention.</time_frame>
    <description>Duplex and color flow ultrasound are used to assess distal blood flow at the popliteal artery for 1 sustained minute following the application of each tourniquet intervention to the middle upper thigh. If no flow is observed for 1 sustained minute then it is considered a successful occlusion. This assessment was made by the investigator and ultrasonographer applying the intervention.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Hemorrhage</condition>
  <condition>Vascular Injury</condition>
  <arm_group>
    <arm_group_label>Pneumatic Tourniquet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>All participants randomly allocated to receive all interventions. Pneumatic Tourniquet: The Automatic Tourniquet System (ATS) 1500 by Zimmer (formerly Aspen Labs) is a pneumatic tourniquet that is typically used in surgical settings, and is representative of best outcome under the ideal circumstances of a controlled environment. The 10 cm (4 inch) wide cylindrical cuff was used for all participants.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Windlass Tourniquet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Windlass Tourniquet with a 3.8 cm (1.5 inch) wide strap is representative of the typical use device in civilian prehospital and military combat environments. In accordance with current prehospital guidelines: If distal perfusion is observed after One Windlass Tourniquet is applied then a second windlass tourniquet will be applied immediately proximal to the first windlass tourniquet so that the participant has Two Windlass Tourniquets applied.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tourniquet Tape 10 cm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tourniquet Tape 10 cm wide is a highly elastic transparent occlusive tape that is expected to create sufficient circumferential pressure to occlude arterial blood flow when tightly wrapped around a limb. The tape should be applied in mostly overlapping layers. The final wrap should be applied without tension to prevent the elastic tension from causing the tape to unwind itself.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tourniquet Tape 5 cm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tourniquet Tape 5 cm wide is a highly elastic transparent occlusive tape that is expected to create sufficient circumferential pressure to occlude arterial blood flow when tightly wrapped around a limb. The tape should be applied in mostly overlapping layers. The final wrap should be applied without tension to prevent the elastic tension from causing the tape to unwind itself.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pneumatic Tourniquet</intervention_name>
    <description>Automated pneumatic tourniquet, applied to middle upper thigh.</description>
    <arm_group_label>Pneumatic Tourniquet</arm_group_label>
    <other_name>Zimmer Automatic Tourniquet System (ATS) 1500</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>One Windlass Tourniquet</intervention_name>
    <description>One Windlass Tourniquet 3.8 cm (1.5 inch) wide. A Special Operations Forces Tactical Tourniquet Wide (SOFTT-W) will be used for the windlass tourniquet. One windlass tourniquet will be applied to the middle upper thigh.</description>
    <arm_group_label>Windlass Tourniquet</arm_group_label>
    <other_name>Special Operations Forces Tactical Tourniquet Wide (SOFTT-W)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Two Windlass Tourniquets</intervention_name>
    <description>Two Windlass Tourniquets will be applied by applying a second 3.8 cm (1.5 inch) wide windlass tourniquet immediately proximal to the first windlass tourniquet.</description>
    <arm_group_label>Windlass Tourniquet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tourniquet Tape 5 cm</intervention_name>
    <description>Tourniquet Tape is 5 cm (2 inch) in width. Tourniquet Tape is a highly elastic transparent occlusive material that can create circumferential pressure when stretched and wrapped around a limb. The tape should be stretched and overlapped by at least half the width as it is applied. The final wrap should be applied without tension.</description>
    <arm_group_label>Tourniquet Tape 10 cm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tourniquet Tape 10 cm</intervention_name>
    <description>Tourniquet Tape is 10 cm (4 inch) in width. Tourniquet Tape is a highly elastic transparent occlusive material that can create circumferential pressure when stretched and wrapped around a limb. The tape should be stretched and overlapped by at least half the width as it is applied. The final wrap should be applied without tension.</description>
    <arm_group_label>Tourniquet Tape 5 cm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Upper thigh circumference greater than 61 cm or 24 inches.

          2. Upper thigh circumference greater than the 50th percentile based on available
             anthropometric data.

        Exclusion Criteria:

          1. Currently taking medications for the treatment of hypertension.

          2. Cardiac, renal, pulmonary, hepatic or hemologic disease or disorder.

          3. Patients with signs or symptoms of vascular insufficiency. Specifically, patients with
             any history of non-healing wound, ulcer, blood clots or peripheral vascular disease
             will be excluded.

          4. Any coagulation disorder, prior thrombotic or embolic events such as a deep vein
             thrombosis.

          5. Sickle cell.

          6. Diabetes mellitus

          7. Rheumatic arthritis or other auto immune disease.

          8. Major surgery, significant traumatic injury, within 60 days trial.

          9. Skin grafts on lower extremities.

         10. Known or observed neurological symptoms, to include peripheral neurological symptoms
             or deficits.

         11. Pregnant women, and women who suspect themselves to be pregnant are not eligible for
             this study.

         12. Any known malignancy.

         13. Claudication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marcus W Migura</last_name>
    <role>Principal Investigator</role>
    <affiliation>Unafiliated</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vascular Medicine &amp; Surgical Associates</name>
      <address>
        <city>Youngstown</city>
        <state>Ohio</state>
        <zip>44501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://archive.rubicon-foundation.org/3476</url>
    <description>NEDU Technical Report No.05-15 Archive Evaluation of Self-Applied Tourniquets for Combat Applications 2005</description>
  </link>
  <link>
    <url>http://archive.rubicon-foundation.org/6870</url>
    <description>NEDU Technical Report No.07-07 Archive Evaluation of Self-Applied Tourniquets for Combat Applications, Second Phase 2007</description>
  </link>
  <link>
    <url>http://www.dtic.mil/dtic/tr/fulltext/u2/a441140.pdf</url>
    <description>USAISR Technical Report No. 2005-05 Laboratory Evaluation of Battlefield Tourniquets in Human Volunteers</description>
  </link>
  <reference>
    <citation>Kragh JF Jr, O'Neill ML, Walters TJ, Dubick MA, Baer DG, Wade CE, Holcomb JB, Blackbourne LH. The military emergency tourniquet program's lessons learned with devices and designs. Mil Med. 2011 Oct;176(10):1144-52.</citation>
    <PMID>22128650</PMID>
  </reference>
  <reference>
    <citation>Wenke JC, Walters TJ, Greydanus DJ, Pusateri AE, Convertino VA. Physiological evaluation of the U.S. Army one-handed tourniquet. Mil Med. 2005 Sep;170(9):776-81.</citation>
    <PMID>16261983</PMID>
  </reference>
  <reference>
    <citation>Taylor DM, Vater GM, Parker PJ. An evaluation of two tourniquet systems for the control of prehospital lower limb hemorrhage. J Trauma. 2011 Sep;71(3):591-5. doi: 10.1097/TA.0b013e31820e0e41.</citation>
    <PMID>21768905</PMID>
  </reference>
  <reference>
    <citation>Swan KG Jr, Wright DS, Barbagiovanni SS, Swan BC, Swan KG. Tourniquets revisited. J Trauma. 2009 Mar;66(3):672-5. doi: 10.1097/TA.0b013e3181986959.</citation>
    <PMID>19276736</PMID>
  </reference>
  <reference>
    <citation>King RB, Filips D, Blitz S, Logsetty S. Evaluation of possible tourniquet systems for use in the Canadian Forces. J Trauma. 2006 May;60(5):1061-71.</citation>
    <PMID>16688072</PMID>
  </reference>
  <reference>
    <citation>Walters TJ, Mabry RL. Issues related to the use of tourniquets on the battlefield. Mil Med. 2005 Sep;170(9):770-5.</citation>
    <PMID>16261982</PMID>
  </reference>
  <reference>
    <citation>Walters TJ, Wenke JC, Kauvar DS, McManus JG, Holcomb JB, Baer DG. Effectiveness of self-applied tourniquets in human volunteers. Prehosp Emerg Care. 2005 Oct-Dec;9(4):416-22.</citation>
    <PMID>16263675</PMID>
  </reference>
  <reference>
    <citation>Ruterbusch VL, Swiergosz MJ, Montgomery LD, Hopper KW, Gerth WA. (U) ONR/MARCORSYSCOM Evaluation of Self-Applied Tourniquets for Combat Applications. Panama City, FL, US : Navy Experimental Diving Unit, November 10, 2005. NEDU Technical Report No.05-15.</citation>
  </reference>
  <reference>
    <citation>Hill JP, Montgomery LD, Hopper KW, Roy LA. (U) ONR/MARCORSYSCOM Evaluation of Self-Applied Tourniquets for Combat Applications, Second Phase. Panama City, FL, US : Navy Experimental Diving Unit, April 3, 2007. NEDU Technical Report No.07-07.</citation>
  </reference>
  <reference>
    <citation>Thomas J. Walters PhD; Joseph C. Wenke PhD; SFC Dominique; Greydanus, USA; David S. Kauvar MD, CPT, MC; David G. Baer PhD. (U) U. S. Army Institute of Surgical Research Laboratory Evaluation of Battlefield Tourniquets in Human Volunteers, Ft. Sam Houston, TX: U. S. Army Institute of Surgical Research, September 30, 2005. USAISR Technical Report No.2005-05</citation>
  </reference>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 27, 2015</study_first_submitted>
  <study_first_submitted_qc>October 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 30, 2015</study_first_posted>
  <results_first_submitted>January 10, 2017</results_first_submitted>
  <results_first_submitted_qc>August 22, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">August 24, 2017</results_first_posted>
  <last_update_submitted>August 22, 2017</last_update_submitted>
  <last_update_submitted_qc>August 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Migura, Marcus</investigator_affiliation>
    <investigator_full_name>Marcus Migura</investigator_full_name>
    <investigator_title>Sponsor-Investigator</investigator_title>
  </responsible_party>
  <keyword>tourniquet</keyword>
  <keyword>arterial</keyword>
  <keyword>pre-hospital</keyword>
  <keyword>SOFTT-W</keyword>
  <keyword>Battle Wrap</keyword>
  <keyword>windlass</keyword>
  <keyword>exsanguination</keyword>
  <keyword>hemorrhage</keyword>
  <keyword>amputation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Vascular System Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data will be de-identified and consolidated into one Excel file and made available online. Still ultrasound images used for primary outcome assessment will be consolidated into one pdf and made available online. Individual participant data that is not supported by clinicaltrials.gov will be posted with Zenodo or by other means. The intent to release de-identified data was disclosed to each volunteer during the informed consent process.</ipd_description>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_type>Primary Outcome Ultrasound Images</doc_type>
      <doc_url>https://doi.org/10.5281/zenodo.236263</doc_url>
      <doc_comment>NCT02592655 Primary Outcome Tourniquet Study</doc_comment>
    </study_doc>
    <study_doc>
      <doc_type>Individual Participant Data Set</doc_type>
      <doc_url>https://doi.org/10.5281/zenodo.237773</doc_url>
      <doc_comment>NCT02592655 Individual level data set</doc_comment>
    </study_doc>
    <study_doc>
      <doc_type>Informed Consent Form</doc_type>
      <doc_url>https://doi.org/10.5281/zenodo.245150</doc_url>
      <doc_comment>Informed consent form containing description of study and procedures.</doc_comment>
    </study_doc>
  </study_docs>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Healthy volunteers with a minimum upper thigh circumference of 61 cm were recruited from the general population during the first two weeks of December 2015.</recruitment_details>
      <pre_assignment_details>Each participant receives a different intervention each period. 19 Participants randomly allocated to unique sequences of four interventions. No participants were lost once enrolled. 5 minute minimum washout period between interventions.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>All Participants</title>
          <description>Each subject has been randomly allocated to a sequence of interventions. Pneumatic tourniquet with a 10 cm (4 inch) wide cylindrical cuff typically used in surgical settings, and is representative of best outcome.
Windlass Tourniquet: The Special Operations Forces Tactical Tourniquet Wide (SOFTT-W) is 3.8 cm (1.5 inch) in width. The SOFTT-W is representative of the typical emergency tourniquet. In accordance with current prehospital guidelines: If a single windlass tourniquet not effective then a second windlass tourniquet will be applied immediately proximal to the first.
Tourniquet Tape 10 cm wide and Tourniquet Tape 5 cm wide are elastic adhesive tape tourniquets.
5 cm tape was discontinued after the 4th participant. Once stretched the tape was too narrow for sufficient overlap. Because the overlap was not sufficient the edges began to roll. This would create an unacceptably narrow band if left in place longer than the prescribed time.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Tourniquet, Left Thigh.</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>ATS (Pneumatic)</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Windlass Tourniquet</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Tourniquet Tape 10 cm Width</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Tourniquet Tape 5 cm Width</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Second Tourniquet Right Thigh.</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>ATS (Pneumatic)</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Windlass Tourniquet</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Tourniquet Tape 10 cm Width</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Tourniquet Tape 5 cm Width</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Third Tourniquet, Left Thigh.</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>ATS (Pneumatic)</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Windlass Tourniquet</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Tourniquet Tape 10 cm Width</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Tourniquet Tape 5 cm Width</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Fourth Tourniquet Right Thigh.</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4">Only the first 4 participants received all four interventions.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>ATS (Pneumatic)</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Windlass Tourniquet</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Tourniquet Tape 10 cm Width</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Tourniquet Tape 5 cm Width</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>&quot;One Windlass&quot; indicates the participants received only one windlass tourniquet because it appeared to be effective. &quot;Two Windlass&quot; describes the participants that received two windlass tourniquets because one did not appear to be effective. The total describes all participants. All participants received both the pneumatic and tape tourniquet.</population>
      <group_list>
        <group group_id="B1">
          <title>One Windlass Tourniquet</title>
          <description>Baseline characteristics for participants that received only one windlass tourniquet.</description>
        </group>
        <group group_id="B2">
          <title>Two Windlass Tourniquets</title>
          <description>Baseline characteristics for participants who had a second windlass tourniquet applied immediately proximal to the first. Meaning that a single windlass tourniquet did not appear effective.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="8"/>
            <count group_id="B2" value="11"/>
            <count group_id="B3" value="19"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30.5" spread="9.5"/>
                    <measurement group_id="B2" value="36.1" spread="8.8"/>
                    <measurement group_id="B3" value="33.7" spread="9.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index (BMI)</title>
          <description>Body Mass Index is the individual participants body weight in kilograms divided by the individual participants height in meters squared.</description>
          <units>Kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.4" spread="1.7"/>
                    <measurement group_id="B2" value="36.1" spread="4.3"/>
                    <measurement group_id="B3" value="32.4" spread="5.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI Weight Status Category (CDC)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>BMI 18.5 – 24.9 Normal</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>BMI 25.0 – 29.9 Overweight</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>BMI 30.0 and Above Obese</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="87.5" spread="11.0"/>
                    <measurement group_id="B2" value="111.3" spread="21.5"/>
                    <measurement group_id="B3" value="101.25" spread="21.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="178.6" spread="9.7"/>
                    <measurement group_id="B2" value="175.0" spread="10.1"/>
                    <measurement group_id="B3" value="176.5" spread="9.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Thigh Circumference</title>
          <description>All thigh circumference measures taken from the participants right thigh while standing.
Upper thigh circumference: Measured just below the gluteal furrow.
10 cm Above Mid Thigh: Circumference measured 10 cm above the mid point between the gluteal furrow and supra-patellar border.
Middle thigh circumference: Circumference measured at the mid point between the gluteal furrow and the supra-patellar border.
Lower Thigh: Circumference measured just above the supra-patellar border.</description>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Upper Thigh</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63.5" spread="3.7"/>
                    <measurement group_id="B2" value="71.2" spread="5.9"/>
                    <measurement group_id="B3" value="68.0" spread="6.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 cm above Mid Thigh</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61.0" spread="4.0"/>
                    <measurement group_id="B2" value="68.7" spread="5.7"/>
                    <measurement group_id="B3" value="65.4" spread="6.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Middle Thigh</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55" spread="4.2"/>
                    <measurement group_id="B2" value="60.3" spread="5.3"/>
                    <measurement group_id="B3" value="58.1" spread="5.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lower Thigh</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42.3" spread="4.4"/>
                    <measurement group_id="B2" value="45.8" spread="3.1"/>
                    <measurement group_id="B3" value="44.3" spread="4.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Percentile of Mean Thigh Circumference</title>
          <description>The mean thigh circumference for the specified set of participants has been compared to the 2010 ANTHROPOMETRIC SURVEY OF U.S. MARINE CORPS PERSONNEL: METHODS AND SUMMARY STATISTICS to determine the nth percentile rank reported. (see references)</description>
          <units>Percentile</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Upper thigh circumference percentile</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65"/>
                    <measurement group_id="B2" value="95"/>
                    <measurement group_id="B3" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lower thigh circumference percentile</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="75"/>
                    <measurement group_id="B2" value="95"/>
                    <measurement group_id="B3" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Systolic Blood Pressure (SBP)</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="130" spread="8.8"/>
                    <measurement group_id="B2" value="136" spread="10.4"/>
                    <measurement group_id="B3" value="133" spread="10.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Limb Occlusion Pressure</title>
          <description>A 10 cm (4 inch) wide pneumatic tourniquet cuff was used with the Automatic Tourniquet System (ATS) 1500 by Aspen Labs to obtain Limb Occlusion Pressures (LOP) on the upper half of each participants thigh. Pulsatile flow was not observable for one sustained minute with duplex ultrasound at the popliteal artery.</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="280" spread="30"/>
                    <measurement group_id="B2" value="319" spread="44"/>
                    <measurement group_id="B3" value="302" spread="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ankle Brachial Index (ABI)</title>
          <description>For each participant the Ankle Brachial Index (ABI) was measured bilaterally, and the highest of the two were used to determine the mean and standard deviation for the specified group reported. An ABI less than 1.0 would be indicative of peripheral artery disease. An ABI greater than 1.4 would be indicative of an incompressible artery.</description>
          <units>Ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.15" spread="0.08"/>
                    <measurement group_id="B2" value="1.16" spread="0.11"/>
                    <measurement group_id="B3" value="1.16" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Radiologist Limb Occlusion Assessment</title>
        <description>Duplex and color flow ultrasound are used to assess distal blood flow at the popliteal artery for 1 sustained minute following the application of a each tourniquet intervention to the middle upper thigh. If no flow is observed for 1 sustained minute then it is considered successful occlusion. A still image is then saved for later evaluation by the blinded outcome assessor.
The 5 cm tape was discontinued after the 4th participant because the tape was considered to unacceptably narrow after stretching and this was considered a mechanical failure even if occlusion was observed. Therefore the 5 cm tape data was not evaluated by the radiologist.</description>
        <time_frame>For 1 sustained minute after application of each tourniquet intervention.</time_frame>
        <population>One ultrasound image from one of the participants of the pneumatic tourniquet (ATS) group failed to capture anatomy and was therefore not included in the analysis.
One ultrasound image from one of the participants of the windlass tourniquet (SOFTT-W) group failed to capture anatomy and was therefore not included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Tourniquet Tape 10 cm</title>
            <description>Tourniquet Tape 10 cm (4 inch) width. Duplex and color flow ultrasound are used to assess distal blood flow at the popliteal artery for 1 sustained minute following the tourniquet tape application. If no flow is observed for 1 sustained minute then the occlusion is considered successful. A still image is then saved for later evaluation by the blinded outcome assessor.</description>
          </group>
          <group group_id="O2">
            <title>Pneumatic Tourniquet</title>
            <description>Automatic pneumatic tourniquet with a 10 cm (4 inch) wide cuff applied to the upper half of the participants thigh. Duplex and color flow ultrasound are used to assess distal blood flow at the popliteal artery for 1 sustained minute following the tourniquet tape application. If no flow is observed for 1 sustained minute then the occlusion is considered successful. A still image is then saved for later evaluation by the blinded outcome assessor.</description>
          </group>
          <group group_id="O3">
            <title>One Windlass Tourniquet</title>
            <description>Duplex and color flow ultrasound are used to assess distal blood flow at the popliteal artery for 1 sustained minute following the application of a one windlass tourniquet to the middle upper thigh. If no flow is observed for 1 sustained minute then it is considered successful occlusion. A still image is then saved for later evaluation by the blinded outcome assessor.</description>
          </group>
          <group group_id="O4">
            <title>Two Windlass Tourniquets</title>
            <description>Duplex and color flow ultrasound are used to assess distal blood flow at the popliteal artery for 1 sustained minute following the application of two windlass tourniquets to the middle upper thigh. If no flow is observed for 1 sustained minute then it is considered successful occlusion. A still image is then saved for later evaluation by the blinded outcome assessor.</description>
          </group>
        </group_list>
        <measure>
          <title>Radiologist Limb Occlusion Assessment</title>
          <description>Duplex and color flow ultrasound are used to assess distal blood flow at the popliteal artery for 1 sustained minute following the application of a each tourniquet intervention to the middle upper thigh. If no flow is observed for 1 sustained minute then it is considered successful occlusion. A still image is then saved for later evaluation by the blinded outcome assessor.
The 5 cm tape was discontinued after the 4th participant because the tape was considered to unacceptably narrow after stretching and this was considered a mechanical failure even if occlusion was observed. Therefore the 5 cm tape data was not evaluated by the radiologist.</description>
          <population>One ultrasound image from one of the participants of the pneumatic tourniquet (ATS) group failed to capture anatomy and was therefore not included in the analysis.
One ultrasound image from one of the participants of the windlass tourniquet (SOFTT-W) group failed to capture anatomy and was therefore not included in the analysis.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="18"/>
                <count group_id="O4" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Success: Absent flow verified by radiologist.</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="18"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Failure: Flow verified by radiologist.</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Null hypothesis is that one windlass tourniquet is just as likely to occlude arterial flow as the 10 cm wide tourniquet tape.
Participant count of 18 to accommodate for missing windlass tourniquet ultrasound data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.002</p_value>
            <p_value_desc>Significance thresh hold: 0.05.</p_value_desc>
            <method>McNemar</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Null hypothesis is that one windlass tourniquet is just as likely to occlude arterial flow as two windlass tourniquets.
Participant count of 18 to accommodate for missing windlass tourniquet ultrasound data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.008</p_value>
            <p_value_desc>Significance thresh hold: 0.05.</p_value_desc>
            <method>McNemar</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Null hypothesis is that the 10 cm wide tourniquet tape is just as likely to occlude arterial flow as using two windlass tourniquets.
Participant count of 18 to accommodate for missing windlass tourniquet ultrasound data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.5</p_value>
            <p_value_desc>Significance thresh hold: 0.05.</p_value_desc>
            <method>McNemar</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Null hypothesis is that using the pneumatic tourniquet is just as likely to occlude arterial flow as using two windlass tourniquets.
Participant count of 17 to accommodate for missing ultrasound data.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.5</p_value>
            <p_value_desc>Significance thresh hold: 0.05.</p_value_desc>
            <method>McNemar</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Investigator Limb Occlusion Assessment</title>
        <description>Duplex and color flow ultrasound are used to assess distal blood flow at the popliteal artery for 1 sustained minute following the application of each tourniquet intervention to the middle upper thigh. If no flow is observed for 1 sustained minute then it is considered a successful occlusion. This assessment was made by the investigator and ultrasonographer applying the intervention.</description>
        <time_frame>For 1 sustained minute after application of each tourniquet intervention.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tourniquet Tape 10 cm</title>
            <description>Tourniquet Tape 10 cm (4 inch) width. Duplex and color flow ultrasound are used to assess distal blood flow at the popliteal artery for 1 sustained minute following the tourniquet tape application. If no flow is observed for 1 sustained minute then the occlusion is considered successful.</description>
          </group>
          <group group_id="O2">
            <title>Pneumatic Tourniquet</title>
            <description>Automatic pneumatic tourniquet with a 10 cm (4 inch) wide cuff applied to the upper half of the participants thigh. Duplex and color flow ultrasound are used to assess distal blood flow at the popliteal artery for 1 sustained minute following the tourniquet tape application. If no flow is observed for 1 sustained minute then the occlusion is considered successful.</description>
          </group>
          <group group_id="O3">
            <title>One Windlass Tourniquet</title>
            <description>Duplex and color flow ultrasound are used to assess distal blood flow at the popliteal artery for 1 sustained minute following the application of one windlass tourniquet to the middle upper thigh. If no flow is observed by the investigators for 1 sustained minute then it is considered successful occlusion.</description>
          </group>
          <group group_id="O4">
            <title>Two Windlass Tourniquets</title>
            <description>Duplex and color flow ultrasound are used to assess distal blood flow at the popliteal artery for 1 sustained minute following the application of the two windlass tourniquets to the middle upper thigh. If no flow is observed by the investigators for 1 sustained minute then it is considered successful occlusion.</description>
          </group>
          <group group_id="O5">
            <title>Tourniquet Tape 5 cm</title>
            <description>Tourniquet Tape 5 cm (2 inch) width. Duplex and color flow ultrasound are used to assess distal blood flow at the popliteal artery for 1 sustained minute following the tourniquet tape application. If no flow is observed for 1 sustained minute then the occlusion is considered successful.</description>
          </group>
        </group_list>
        <measure>
          <title>Investigator Limb Occlusion Assessment</title>
          <description>Duplex and color flow ultrasound are used to assess distal blood flow at the popliteal artery for 1 sustained minute following the application of each tourniquet intervention to the middle upper thigh. If no flow is observed for 1 sustained minute then it is considered a successful occlusion. This assessment was made by the investigator and ultrasonographer applying the intervention.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="19"/>
                <count group_id="O3" value="19"/>
                <count group_id="O4" value="11"/>
                <count group_id="O5" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Success: Absent flow observed by investigator.</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="19"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="9"/>
                    <measurement group_id="O5" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Failure: Flow observed by investigator.</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 day</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Pneumatic Tourniquet</title>
          <description>The Automatic Tourniquet System (ATS) 1500 by Zimmer (formerly Aspen Labs) was used with a 10 cm (4 inch) wide pneumatic cuff.</description>
        </group>
        <group group_id="E2">
          <title>Windlass Tourniquet</title>
          <description>One or two windlass tourniquets applied as needed to achieve study objectives.</description>
        </group>
        <group group_id="E3">
          <title>Tourniquet Tape 5 cm</title>
          <description>Tourniquet Tape 5 cm (2 inch) width. A highly elastic transparent occlusive material that can create circumferential pressure when stretched and wrapped around a limb.</description>
        </group>
        <group group_id="E4">
          <title>Tourniquet Tape 10 cm</title>
          <description>Tourniquet Tape, 10 cm (4 inch) width. A highly elastic transparent occlusive material that can create circumferential pressure when stretched and wrapped around a limb.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="19"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Tourniquet tape 5 cm ended early due to excessive narrowing, resulting in data loss.
The pressure mapping system proved subjective in use and software bugs resulted corrupt data files.
Small sample size, therefore only large individuals enrolled.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Marcus Migura</name_or_title>
      <organization>Marcus Migura</organization>
      <phone>(619) 436-7323</phone>
      <email>mwmigura@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

